【レポートの概要（一部）】
TABLE OF CONTENTS
1 INTRODUCTION
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 STAKEHOLDERS
1.4 RESEARCH METHODOLOGY
1.4.1 MARKET SIZE
1.4.2 KEY DATA POINTS FROM SECONDARY SOURCES
1.4.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 MARKET OVERVIEW
3.1 DEFINITION OF BIOMARKERS
3.2 BIOMARKERS & ITS TYPES
3.3 BIOMARKERS MARKET
3.3.1 MARKET SEGMENTATION
3.3.2 CHALLENGES & OPPORTUNITIES
3.3.2.1 Challenges
3.3.2.1.1 Variability
3.3.2.1.2 Ethical considerations & acceptability
3.3.2.2 Opportunities
3.3.2.2.1 Personalized medicine
3.3.2.2.2 Companion diagnostics
3.3.3 DRIVERS & RESTRAINTS
3.3.3.1 Drivers
3.3.3.1.1 High demand boosts the growth of the biomarkers market globally
3.3.3.1.2 Strategic collaborations lead to increasing applications in the market
3.3.3.1.3 Technological advances contribute to growth
3.3.3.1.4 The rising prevalence of the disease forms
3.3.3.1.5 FDA support for biomarkers development
3.3.3.2 Restraints
3.3.3.2.1 Low capital investment & cost-benefit hinders growth of biomarkers
3.3.3.2.2 Biomarkers not a profitable market for small organizations
3.3.3.2.3 Sample collection & storage
3.3.3.2.4 Limited biomarkers validation
3.3.3.2.5 Need for new R&D models with greater precision & flexibility
4 GLOBAL BIOMARKERS MARKET, BY DISCOVERY TECHNOLOGIES
4.1 INTRODUCTION
4.2 IMAGING TECHNOLOGIES FOR BIOMARKERS DISCOVERY
4.2.1 POSITRON EMISSION TOMOGRAPHY (PET)
4.2.2 SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY(SPECT)
4.2.3 ULTRASOUND
4.2.4 MAGNETIC RESONANCE IMAGING (MRI)
4.2.5 COMPUTED TOMOGRAPHY (CT)
4.3 OMICS TECHNOLOGIES FOR BIOMARKERS DISCOVERY
4.3.1 PROTEOMICS
4.3.1.1 Mass spectrometry
4.3.1.1.1 MALDI mass spectrometry
4.3.1.1.2 Imaging mass spectrometry
4.3.1.2 2D Gel Electrophoresis
4.3.1.3 Protein microarray technology
4.3.1.4 Antibody array technology
4.3.1.5 Peptide array technology
4.3.2 GENOMICS
4.3.2.1 Whole genome sequencing
4.3.2.2 Genotyping
4.3.2.3 Epigenetics
4.3.3 TRANSCRIPTOMICS
4.3.3.1 Microarrays
4.3.3.2 Gene expression profiling
4.3.4 METABOLOMICS
4.3.4.1 Capillary electrophoresis
4.3.4.2 Mass spectrometry based kits
4.3.4.3 Nuclear Magnetic Resonance(NMR)
4.4 BIOINFORMATICS
4.4.1 CLUSTER ANALYSIS
4.4.2 STATISTICAL ANALYSIS
4.4.3 CELL SIGNAL PATHWAYS
4.4.4 COMPUTER AIDED DESIGN
4.4.5 DATA MINING
4.4.6 PROTEIN INTERACTION MAPS
5 SERVICES MARKET OF BIOMARKERS
5.1 INTRODUCTION
5.2 CLINICAL
5.2.1 SAMPLE PREPARATION
5.2.2 ASSAY DEVELOPMENT
5.2.3 BIOMARKERS VALIDATION & TESTING
5.2.3.1 Feasibility Studies and choice of assay & biomarkers
5.2.3.2 Long lead time required for Biomarkers Assay preparation
5.3 BIOINFORMATICS
5.3.1 FUNCTIONAL GENOMICS & PROTEOMICS DRIVE THE DEMAND FOR BIOINFORMATICS
6 BIOMARKERS APPLICATION MARKET
6.1 INTRODUCTION
6.2 DRUG DISCOVERY & DEVELOPMENT
6.2.1 CLINICAL TRIALS
6.2.1.1 Preclinical Development
6.2.1.2 Phase I drug development
6.2.1.3 Phase II drug development
6.2.1.4 Phase III drug development
6.2.1.5 Phase IV drug development
6.3 PERSONALIZED MEDICINE
6.4 MOLECULAR DIAGNOSTICS
6.4.1 MOLECULAR DIAGNOSTICS IS A DYNAMIC & RAPIDLY BROADENING MARKET
6.4.2 TRENDS IN THE DIAGNOSTICS MARKET
6.4.3 CHALLENGES
6.4.3.1 Nucleic acids pose a challenge to the molecular diagnostics field
6.4.3.2 Molecular diagnostics market lacks a collaborated effort
6.4.4 DRIVER
6.4.4.1 Increase in the incidence of diseases spurs the growth of the diagnostics market
6.4.5 RESTRAINT
6.4.5.1 The “interest-information” restricts growth of molecular diagnostics
6.4.6 MOLECULAR DIAGNOSTICS IN MAJOR INDICATIONS
6.4.6.1 Oncology
6.4.6.2 Cardiology
6.4.6.3 Neurology
6.4.6.4 Other treatment areas
6.4.7 BIOMARKERS IN DIAGNOSTICS
6.4.8 BENEFITS OF MOLECULAR DIAGNOSTICS
7 BIOMARKERS INDICATION MARKET
7.1 INTRODUCTION
7.2 ONCOLOGY BIOMARKERS MARKET
7.2.1 ONCOLOGY BIOMARKERS DISCOVERY MARKET
7.2.1.1 Genomics
7.2.1.2 Proteomics
7.2.1.3 Metabolomics
7.2.1.4 Transcriptomics
7.2.1.5 Other Omics
7.2.1.6 Imaging
7.2.2 DRUG DISCOVERY & DEVELOPMENT
7.2.3 CANCER TYPES
7.2.3.1 Ovarian Cancer
7.2.3.2 Breast Cancer
7.2.3.3 Bladder Cancer
7.2.3.4 Cervical Cancer
7.2.3.5 Prostate Cancer
7.2.3.6 Lung Cancer
7.2.3.7 Colorectal Cancer
7.3 CARDIOLOGY BIOMARKERS MARKET
7.3.1 CARDIOLOGY BIOMARKERS DISCOVERY MARKET
7.3.1.1 Genomics
7.3.1.2 Proteomics
7.3.1.3 Metabolomics
7.3.1.4 Transcriptomics
7.3.1.5 Imaging
7.3.1.6 Bioinformatics
7.3.2 DRUG DISCOVERY & DEVELOPMENT
7.3.3 CARDIAC MARKERS, BY DISEASE TYPES
7.3.3.1 Acute Coronary Syndrome
7.3.3.2 Coronary artery disease
7.3.3.3 Stroke
7.3.4 CARDIOLOGY BIOMARKERS USED IN THE MARKET
7.4 NEUROLOGY BIOMARKERS MARKET
7.4.1 NEUROLOGY BIOMARKERS DISCOVERY MARKET
7.4.1.1 Omics technologies
7.4.1.2 Imaging Technologies
7.4.2 DRUG DISCOVERY & DEVELOPMENT
7.4.3 DISEASE TYPES
7.4.3.1 Alzheimer’s disease
7.4.3.2 Parkinson’s disease
7.4.3.3 Multiple sclerosis
7.4.3.4 Schizophrenia
7.4.3.5 Amyotrophic Lateral Sclerosis
7.4.3.6 Epilepsy
7.5 OTHER INDICATIONS BIOMARKERS MARKET
7.5.1 OTHER INDICATION BIOMARKERS DISCOVERY MARKET
7.5.1.1 Omics technologies
7.5.1.2 Imaging technologies
7.5.2 DRUG DISCOVERY & DEVELOPMENT
7.6 DISEASE TYPES
7.6.1 HIV
7.6.1.1 Immunological & Virological Markers in HIV Infection
7.7 RENAL FAILURE
7.8 ARTHRITIS
7.9 TUBERCULOSIS
7.10 DIABETES
8 GEOGRAPHICAL ANALYSIS
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.3 EUROPE
8.4 ASIA
8.5 ROW
9 COMPETITIVE LANDSCAPE
9.1 KEY STRATEGIES
9.2 MERGERS & ACQUISITIONS
9.3 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES
9.4 NEW PRODUCTS LAUNCH
9.5 OTHER DEVELOPMENTS
10 COMPANY PROFILES
10.1 ABBOTT LABORATORIES
10.1.1 OVERVIEW
10.1.2 FINANCIALS
10.1.3 PRODUCTS & SERVICES
10.1.4 STRATEGY
10.1.5 DEVELOPMENTS
10.2 ABCODIA LTD
10.2.1 OVERVIEW
10.2.2 FINANCIALS
10.2.3 PRODUCTS & SERVICES
10.2.4 STRATEGY
10.2.5 DEVELOPMENTS
10.3 AFFYMETRIX INC
10.3.1 OVERVIEW
10.3.2 FINANCIALS
10.3.3 PRODUCTS & SERVICES
10.3.4 STRATEGY
10.3.5 DEVELOPMENTS
10.4 AGILENT TECHNOLOGIES INC
10.4.1 OVERVIEW
10.4.2 FINANCIALS
10.4.3 PRODUCTS & SERVICES
10.4.4 STRATEGY
10.4.5 DEVELOPMENTS
10.5 AMGEN INC
10.5.1 OVERVIEW
10.5.2 FINANCIALS
10.5.3 PRODUCTS & SERVICES
10.5.4 STRATEGY
10.5.5 DEVELOPMENT
10.6 ASTRAZENECA PLC
10.6.1 OVERVIEW
10.6.2 FINANCIALS
10.6.3 PRODUCTS & SERVICES
10.6.4 STRATEGY
10.6.5 DEVELOPMENTS
10.7 AUGUREX LIFE SCIENCES CORP
10.7.1 OVERVIEW
10.7.2 FINANCIALS
10.7.3 PRODUCTS & SERVICES
10.7.4 STRATEGY
10.7.5 DEVELOPMENTS
10.8 AUSHON BIOSYSTEMS INC
10.8.1 OVERVIEW
10.8.2 FINANCIALS
10.8.3 PRODUCTS & SERVICES
10.8.4 STRATEGY
10.8.5 DEVELOPMENTS
10.9 BAYER AG
10.9.1 OVERVIEW
10.9.2 FINANCIALS
10.9.3 PRODUCTS & SERVICES
10.9.4 STRATEGY
10.9.5 DEVELOPMENTS
10.1 BECKMAN COULTER INC
10.10.1 OVERVIEW
10.10.2 FINANCIALS
10.10.3 PRODUCTS & SERVICES
10.10.4 STRATEGY
10.10.5 DEVELOPMENTS
10.11 BGI
10.11.1 OVERVIEW
10.11.2 FINANCIALS
10.11.3 PRODUCTS & SERVICES
10.11.4 STRATEGY
10.11.5 DEVELOPMENTS
10.12 BIOCRATES LIFE SCIENCES AG
10.12.1 OVERVIEW
10.12.2 FINANCIALS
10.12.3 PRODUCTS & SERVICES
10.12.4 STRATEGY
10.12.5 DEVELOPMENTS
10.13 BIOMARKERS STRATEGIES
10.13.1 OVERVIEW
10.13.2 FINANCIALS
10.13.3 PRODUCTS & SERVICES
10.13.4 STRATEGY
10.13.5 DEVELOPMENTS
10.14 BIOSYSTEMS INTERNATIONAL
10.14.1 OVERVIEW
10.14.2 FINANCIALS
10.14.3 PRODUCTS & SERVICES
10.14.4 STRATEGY
10.14.5 DEVELOPMENTS
10.15 BRISTOL-MYERS SQUIBB
10.15.1 OVERVIEW
10.15.2 FINANCIALS
10.15.3 PRODUCTS & SERVICES
10.15.4 STRATEGY
10.15.5 DEVELOPMENTS
10.16 CRESCENDO BIOSCIENCE
10.16.1 OVERVIEW
10.16.2 FINANCIALS
10.16.3 PRODUCTS & SERVICES
10.16.4 STRATEGY
10.16.5 DEVELOPMENTS
10.17 EISAI CO. LTD.
10.17.1 OVERVIEW
10.17.2 FINANCIALS
10.17.3 PRODUCTS & SERVICES
10.17.4 STRATEGY
10.17.5 DEVELOPMENTS
10.18 EPIONTIS GMBH
10.18.1 OVERVIEW
10.18.2 FINANCIALS
10.18.3 PRODUCTS & SERVICES
10.18.4 DEVELOPMENTS
10.19 EPISTEM HOLDINGS PLC
10.19.1 OVERVIEW
10.19.2 FINANCIALS
10.19.3 PRODUCTS & SERVICES
10.19.4 STRATEGY
10.19.5 DEVELOPMENTS
10.20 EUROGENTEC S.A.
10.20.1 OVERVIEW
10.20.2 FINANCIALS
10.20.3 PRODUCTS & SERVICES
10.20.4 STRATEGY
10.20.5 DEVELOPMENTS
10.21 EVOTEC AG
10.21.1 OVERVIEW
10.21.2 FINANCIALS
10.21.3 PRODUCTS & SERVICES
10.21.4 STRATEGY
10.21.5 DEVELOPMENTS
10.22 GLAXOSMITHKLINE PLC
10.22.1 OVERVIEW
10.22.2 FINANCIALS
10.22.3 PRODUCTS & SERVICES
10.22.4 STRATEGY
10.22.5 DEVELOPMENTS
10.23 IPSEN
10.23.1 OVERVIEW
10.23.2 FINANCIALS
10.23.3 PRODUCTS & SERVICES
10.23.4 STRATEGY
10.23.5 DEVELOPMENTS
10.24 JOHNSON & JOHNSON
10.24.1 OVERVIEW
10.24.2 FINANCIALS
10.24.3 PRODUCTS & SERVICES
10.24.4 STRATEGY
10.24.5 DEVELOPMENTS
10.25 MERCK & CO.
10.25.1 OVERVIEW
10.25.2 FINANCIALS
10.25.3 PRODUCTS & SERVICES
10.25.4 STRATEGY
10.25.5 DEVELOPMENTS
10.26 MICROMEDIC TECHNOLOGIES LTD
10.26.1 OVERVIEW
10.26.2 PRODUCTS & SERVICES
10.26.3 STRATEGY
10.26.4 DEVELOPMENTS
10.27 MYRIAD GENETICS INC
10.27.1 OVERVIEW
10.27.2 FINANCIALS
10.27.3 PRODUCTS & SERVICES
10.27.4 STRATEGY
10.27.5 DEVELOPMENTS
10.28 NEXTGEN SCIENCES INC
10.28.1 OVERVIEW
10.28.2 FINANCIALS
10.28.3 PRODUCTS & SERVICES
10.28.4 STRATEGY
10.28.5 DEVELOPMENTS
10.29 NOVARTIS INTERNATIONAL AG
10.29.1 OVERVIEW
10.29.2 FINANCIALS
10.29.3 PRODUCTS & SERVICES
10.29.4 STRATEGY
10.29.5 DEVELOPMENTS
10.30 OCIMUM BIOSOLUTIONS LTD
10.30.1 OVERVIEW
10.30.2 FINANCIALS
10.30.3 PRODUCTS & SERVICES
10.30.4 STRATEGY
10.30.5 DEVELOPMENTS
10.31 PFIZER INC
10.31.1 OVERVIEW
10.31.2 FINANCIALS
10.31.3 PRODUCTS & SERVICES
10.31.4 STRATEGY
10.31.5 DEVELOPMENTS
10.32 PRONOTA NV
10.32.1 OVERVIEW
10.32.2 FINANCIALS
10.32.3 PRODUCTS & SERVICES
10.32.4 STRATEGY
10.32.5 DEVELOPMENTS
10.33 QUINTILES TRANSNATIONAL CORPORATION
10.33.1 OVERVIEW
10.33.2 FINANCIALS
10.33.3 PRODUCTS & SERVICES
10.33.4 STRATEGY
10.33.5 DEVELOPMENTS
10.34 QIAGEN NV
10.34.1 OVERVIEW
10.34.2 FINANCIALS
10.34.3 PRODUCTS & SERVICES
10.34.4 STRATEGY
10.34.5 DEVELOPMENTS
10.35 ROCHE DIAGNOSTICS LIMITED
10.35.1 OVERVIEW
10.35.2 FINANCIALS
10.35.3 PRODUCTS & SERVICES
10.35.4 STRATEGY
10.35.5 DEVELOPMENT
10.36 SANOFI-AVENTIS
10.36.1 OVERVIEW
10.36.2 FINANCIALS
10.36.3 PRODUCTS & SERVICES
10.36.4 STRATEGY
10.36.5 DEVELOPMENT
10.37 SIEMENS HEALTHCARE
10.37.1 OVERVIEW
10.37.2 FINANCIALS
10.37.3 PRODUCTS & SERVICES
10.37.4 STRATEGY
10.37.5 DEVELOPMENTS
10.38 TRANS-HIT BIOMARKERS INC
10.38.1 OVERVIEW
10.38.2 FINANCIALS
10.38.3 PRODUCTS & SERVICES
10.38.4 STRATEGY
10.38.5 DEVELOPMENTS
10.39 PACIFIC BIOMARKERS INC
10.39.1 OVERVIEW
10.39.2 FINANCIALS
10.39.3 PRODUCTS & SERVICES
10.39.4 STRATEGY
10.39.5 DEVELOPMENTS
10.40 CAPRION PROTEOMICS INC.
10.40.1 OVERVIEW
10.40.2 FINANCIALS
10.40.3 PRODUCTS & SERVICES
10.40.4 STRATEGY
10.40.5 DEVELOPMENTS
10.41 PROTEOME SCIENCES PLC
10.41.1 OVERVIEW
10.41.2 FINANCIALS
10.41.3 PRODUCTS & SERVICES
10.41.4 STRATEGY
10.41.5 DEVELOPMENTS
10.42 VERMILLION INC
10.42.1 OVERVIEW
10.42.2 FINANCIALS
10.42.3 PRODUCTS & SERVICES
10.42.4 STRATEGY
10.42.5 DEVELOPMENTS
【レポート販売概要】
■ タイトル：世界のバイオマーカー市場■ 英文：Biomarkers Market - ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, Neurology]) - Global Trends & Forecasts (2013-2018)
■ 発行日：2013年9月
■ 調査会社：MarketsandMarkets
■ 商品コード：BT 2120
■ 調査対象地域：グローバル
- コネクテッド・ロジスティクスの世界市場予測（～2021年）“The evolution of connected vehicles and increasing logistics transparency across the globe and the increasing adoption of connected and intelligent devices are some of the factors expected to drive the connected logistics market” The connected logistics market size is estimated to grow from USD 10.04 billion in 2016 to USD 41.30 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 32.7%. T …
- 世界のスマートテレビ用高周波デバイス市場：アンテナ・スイッチ、復調器、パワーアンプ、RFフィルタ、チューナーAbout Smart TV RF Devices Smart TV, also known as connected TV or hybrid TV, is a TV with integrated internet capabilities or a TV set-top box that offers advanced connectivity and computing abilities. Smart TV allows users to install and run advanced applications based on specific platforms. RF devices use RF technology and are deployed in various wired and wireless communication devices such as …
- French Hospital Hematology and Flow Cytometry Market 2014This new report from Venture Planning Group contains 231 pages, 13 tables, and presents a comprehensive analysis of the French hospital hematology and flow cytometry markets, including: Major issues pertaining to the French hematology and flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next te …
- クラウド型BPOの世界市場2015-2019About cloud-based BPO Over the years, enterprises worldwide have become increasingly dependent on technology and various software products to run their business and drive revenue growth. This trend is expected to intensify, and therefore the role of outsourcing the business processes to third party vendors has become vital and it directly contributes to the organization’s agenda. Cloud computing h …
- 産業用通信の世界市場予測（～2022年）：構成品、ソフトウェア、サービスAccording to the new market research report on industrial communication, this market is expected to be worth USD 130.33 Billion by 2022, growing at a CAGR of 12.36% between 2016 and 2022. The major driver for the growth is the increasing adoption of Industrial Internet of Things (IIoT). In various manufacturing industries, the potential for IIoT to improve the productivity in production processes …
- AaaS（Analytics as a Service）ソリューションの世界市場Analytics-as-a-Service (AaaS) has become important for businesses to remain competitive in the global market when it comes to getting analytics cloud driven. The analytics-as-a-service market has been segmented by solution, service, deployment model, end-user organization size, and industry vertical within the global market. AaaS solutions and services providers play a vital role in assisting vari …
- IoT接続の世界市場予測（～2024年）The proliferation of connected devices to drive the IoT connectivity marketMarketsandMarkets expects the IoT Connectivity market to grow from USD 3.8 billion in 2019 to USD 8.9 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 18.7% from 2019 to 2024. Organizations are adopting advanced technologies, such as the IoT and cloud services, achieving successful digital transformation. IoT gen …
- 教育ERPソリューションの世界市場予測（～2021年）The education ERP market is projected to grow from USD 6.77 Billion in 2016 to USD 14.19 Billion by 2021, at a CAGR of 15.9% from 2016 to 2021. The education ERP market is gaining significant importance among various users due to increasing demand for automated management of varied business processes in academic institutions. Hence, increased adoption of education ERP solutions in the academic sec …
- スティック型包装材の世界市場：ポリエステル、紙、BOPP、アルミニウム、金属化ポリエステル、ポリエチレン、ポリプロピレンStick packaging is a type of flexible packaging. It is named after the shape it has: thin and long. Stick packaging is easy to handle, conveniently small, and suitable for on-the-go products. Industries such as food, pharmaceuticals, or manufacturers of single-dose products prefer using stick packs for their products. The stick packaging market in the Asia-Pacific region is projected to grow at th …
- 不織布-産業用メンブレンの世界市場予測（～2021年）MarketsandMarkets projects that the market for non-woven fabrics industrial membranes will grow from USD 608.9 Million in 2016 to USD 959.5 Million by 2021, at a CAGR of 9.52%. This market is growing because of the increase in demand for fresh water from industries such as medicals, infrastructures, and construction activities. The growth in demand for desalination is also expected to positively i …
- ブラジル/ロシア/インド/中国の電気生理学（Electrophysiology）処置動向（～2020）BRIC Electrophysiology Procedures Outlook to 2020 Summary GlobalData’s new report, "BRIC Electrophysiology Procedures Outlook to 2020", provides key procedures data on the BRIC Electrophysiology Procedures. The report provides procedure volumes within market category – Electrophysiology Ablation Procedures. The data in the report is derived from dynamic market forecast models. GlobalData uses epid …
- 貯蔵タンクの世界市場：タイプ別（ステンレス、コンクリート）、用途別（石油化学工業、製紙・パルプ産業、食品産業、バイオ燃料製造プラント）、地域別予測Global Storage Tanks Market to reach USD XXX billion by 2025. Global Storage Tanks Market valued approximately USD XXX billion in 2016 is forecasted to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. A storage tank is a large vessel for storing liquids, like oil, gas, and many petrochemical products. These tanks tend to be vertical cylindrical, i.e. have rounde …
- CINV（化学療法による悪心・嘔吐）治療薬の世界市場2015-2019About CINV CINV is one of the most dreaded adverse effects of chemotherapy. It often leads to the postponement or refusal of potentially curative chemotherapy treatment for cancer. This nausea and vomiting, associated with chemotherapy regimen, affects the quality of life of an individual. The neurotransmitters in CINV are dopamine, 5-HT3, substance P, and endocannabinoids. CINV can be caused by t …
- ゲーム機の世界市場：テレビゲーム機、携帯型ゲーム機About Gaming Console Gaming consoles are the most popular devices among the various gaming platforms available in the market. These specialized computers are designed for interactive video gaming and are built with similar components, such as a central processing unit (CPU), graphics processing unit (GPU), and random access memory (RAM). Peripherals such as joysticks, mouse, keypads, and others ar …
- モジュール型UPS（無停電電源装置）の世界市場The global modular Uninterruptible Power Supply (UPS) market is expected to reach USD 1,425.2 million in 2015 and is estimated to grow at a Compound Annual Growth Rate (CAGR) of 12.7% during the forecast period of 2015–2020. Asia-Pacific is expected to account for the largest share of the global modular UPS market by 2020. The trend of adoption of this technology in this region is mainly driven by …
